Skip to content

Clinical trials

Terminated Neuroblastoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuroblastoma Status: Terminated Country / region: United States Clear all

60 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20031
20041
20063
20074
20087
20094
20105
20115
20134
20142
20153
20164
20182
20191
20205
20213
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated60

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center4
National Cancer Institute (NCI)4
City of Hope Medical Center3
Giselle Sholler3
Masonic Cancer Center, University of Minnesota3
Vanderbilt-Ingram Cancer Center3
Y-mAbs Therapeutics3
Columbia University2
Memorial Sloan Kettering Cancer Center2
Novartis Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuroblastoma60
Lymphoma13
Lymphoma, Non-Hodgkin12
Neoplasms12
Testicular Neoplasms12
Burkitt Lymphoma11
Hodgkin Disease11
Leukemia, Myeloid, Acute11
Lymphoma, Large B-Cell, Diffuse11
Multiple Myeloma11

Trials

Showing 1 to 25 of 60. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.